Society guideline links: Juvenile idiopathic arthritis

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Psoriatic arthritis in adults" and "Society guideline links: Spondyloarthritis".)

International

●International task force recommendations for treating juvenile idiopathic arthritis to target (2018)

●European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR)/Paediatric Rheumatology International Trials Organisation (PRINTO): Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis (2016)

Canada

●Canadian Rheumatology Association (CRA): Management of juvenile idiopathic arthritis – A position statement, 2015 (published 2016)

United States

●American College of Rheumatology (ACR)/Arthritis Foundation (AF): Guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis (2019)

●ACR/AF: Guideline for the treatment of juvenile idiopathic arthritis – Therapeutic approaches for non-systemic polyarthritis, sacroiliitis, and enthesitis (2019)

●Choosing Wisely: Do not order rheumatoid factor (RF) alone, or as part of a "panel" or "cascade" in children to evaluate for rheumatologic disease such as juvenile idiopathic arthritis (JIA) due to musculoskeletal complaints. Do not let laboratory results guide referral (2019)

●Childhood Arthritis and Rheumatology Research Alliance (CARRA): Consensus treatment plans for juvenile idiopathic arthritis-associated and idiopathic chronic anterior uveitis (2018)

●European League Against Rheumatism (EULAR)/ACR/Paediatric Rheumatology International Trials Organisation (PRINTO): Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis (2016)

●Choosing Wisely: Don't repeat a confirmed positive ANA in patients with established JIA or systemic lupus erythematosus (SLE) (2013)

●Choosing Wisely: Don't routinely perform surveillance joint radiographs to monitor juvenile idiopathic arthritis (JIA) disease activity (2013)

●CARRA: Consensus treatment plans for new‐onset systemic juvenile idiopathic arthritis (2012)

Europe

●Single Hub and Access point for pediatric Rheumatology in Europe (SHARE) initiative: Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis (2018)

●European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR)/Paediatric Rheumatology International Trials Organisation (PRINTO): Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis (2016)

●EULAR-Pediatric Rheumatology European Society (PReS): Recommendation on points to consider for the use of imaging in the diagnosis and management of juvenile idiopathic arthritis in clinical practice (2015)

United Kingdom

●British Society for Rheumatology (BSR): Guidance for screening for uveitis in juvenile idiopathic arthritis (JIA) (2018)

●BSPAR: Standards of care for children and young people with juvenile idiopathic arthritis (2010)

Japan

●Japan College of Rheumatology (JCR): Clinical practice guidance for juvenile idiopathic arthritis (JIA) (2018)